Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Hengrui Pharmaceuticals Receives Clinical Trial Approvals for Three New Drugs
January 31, 2025
Company
Deals
Rainsure Scientific Secures Series C1 Funding for Digital PCR Development
January 31, 2025
Company
Drug
CSPC Pharma’s rhTNK-tPA Accepted for Review by NMPA for Stroke Indication
January 31, 2025
Company
Deals
Asia Pacific Medical Group Secures Series A Funding for Hospital Expansion
January 31, 2025
Company
Drug
Haisco’s HSK31858 Gains Ethical Approval for Phase II Study in NCFBE
January 31, 2025
Company
Drug
CANbridge’s CAN106 Receives Orphan Drug Designation for Myasthenia Gravis
January 31, 2025
Company
Deals
HitGen Partners with Guangzhou AIChemEco for Automated Synthesis Technology
January 31, 2025
Company
Harbour BioMed Establishes Nona Biosciences for Next-Generation Antibody Development
January 31, 2025
Company
Novartis Considers Sale of Non-Core Units to Fund Innovation
January 31, 2025
Company
Deals
Sequanta Technologies Partners with Illumina to Introduce NovaSeq X Series
January 31, 2025
Company
Drug
Ascletis Pharma’s PD-L1 Inhibitor ASC61 Gains NMPA IND Approval
January 31, 2025
Company
Deals
MicroTech Medical Plans IPO on Shanghai’s STAR Market
January 31, 2025
1
2
…
8
9
10
11
12
…
24
25
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
